Answers are grounded in this paper and cite their sources.
Proposed trial investigates combined nutraceutical effects on sexual function in women, suggesting new therapeutic options.
Background: Female Sexual Dysfunction (FSD) is a multifactorial condition reported to affect a substantial proportion of wom en, with limited approved therapeutic options. Proposal: This paper proposes a hypothesis-driven, over-the-counter nutraceutical combination intended to address several proposed mechanisms relevant to FSD and outlines a translational research pathway in silico, preclinical, and Phase II clinical to test that hypothesis. No combined formulation of these eight ingredients has been tested to date; the synergy described here is a research hypothesis, not an established finding. Methods: A narrative review identified eight nutraceuticals with individual-ingredient evidence plausibly relevant to FSD mechanisms: Resveratrol, Ashwagandha, Tribulus terrestris, L-Arginine, Black Cohosh, Evening Primrose Oil, Shilajit, and Visnadine. Proposed outcomes: If the proposed research program is carried out, it may clarify whether combined administration affects vasodilation, hormonal measures, oxidative stress markers, and patient-reported sexual function outcomes. These are hypothesized endpoints, not demonstrated results. Conclusion: A multi-mechanism nutraceutical approach to FSD is a reasonable hypothesis worth testing given the individual-ingredient evidence base, but currently rests on inference from single-ingredient studies rather than combination data.
No takes yet. Share an insight, caveat, or question.
Saleh et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: